RE: Delayed Trades - Big Numbers17 Nov 2020 19:48
Hi Woodstock, funnily enough that was something (dropping the trial) that occurred to me after the first vaccine announcement which, let’s face it, was groundbreaking news.
However I do not think it is either likely OR possible that this would happen. It would cause a catastrophic fall in the SP and shred the companies reliability and trust within the market irrevocably. No, even if they considered it, which I do not believe they have, there is zero chance they could do it.
Also, they have categorically stated COPD is firmly on the back burner. Again, credibility is at stake here. No they are ploughing on with COVID (quite rightly) full steam ahead.
I am concerned though at the unnecessary confusion they cause by not communicating trial activity and progress on an ongoing basis. How many times have had to resort to super sleuth detective work to try and figure out what the heck is going on over the past few months. Finding the trial on clinical trials.gov but no clarification from the company was a good case in point. Imo they’ve been poor in this area and we’ve all been left guessing, just like we are again today.
It’s not good enough. RM needs to issue an RNS tomorrow to clear things up and stop the confusion and second guessing by investors.